Yook, S.; Cai, Z.; Jeong, J. J.; Lu, Y.; Winnik, M. A.; Pignol, J. - P.; Reilly, R. M. A Dual Receptor-Targeted (Drt) Radiation Nanomedicine Labeled With 177Lu Is More Potent For Killing Human Breast Cancer Cells In Vitro That Co-Express Her2 And Egfr Than Single Receptor-Targeted (Srt) Radiation Nanomedicines. Mol. Pharmaceutics 2020, 17, 1226?1236.

Cai, Z.; Yook, S.; Lu, Y.; Bergstrom, D.; Winnik, M. A.; Pignol, J. - P.; Reilly, R. M. Local Radiation Treatment Of Her2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled With 177Lu. Pharmaceutical Research 2017, 34, 579?590.

Yook, S.; Cai, Z.; Lu, Y.; Winnik, M. A.; Pignol, J.; Reilly*, R. M. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy With Application For Neoadjuvant Treatment Of Locally Advanced Breast Cancer. J. Nucl. Med. 2016, 57, 936?942.

Yook, S.; Lu, Y.; Jeong, J. J.; Cai, Z.; Tong, L.; Alwarda, R.; Pignol, J. P.; Winnik, M. A.; Reilly*, R. M. Stability And Biodistribution Of Thiol-Functionalized And 177Lu-Labeled Metal Chelating Polymers (Mcp) Bound To Gold Nanoparticles. Biomacromolecules 2016, 17, 1292?1302.

Yook, S.; Cai, Z.; Lu, Y.; Winnik, M. A.; Pignol, J.; Reilly*, R. M. Radiation Nanomedicine For Egfr-Positive Breast Cancer Panitumumab Modified Gold Nanoparticles Complexed To The - Particle-Emitter, 177Lu. Mol. Pharmaceutics 2015, 12, 3963?72.